0001628280-21-001279.txt : 20210202
0001628280-21-001279.hdr.sgml : 20210202
20210202151823
ACCESSION NUMBER: 0001628280-21-001279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210129
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayden Michael R
CENTRAL INDEX KEY: 0001352908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 21580986
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z 7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_161229708841560.xml
FORM 4
X0306
4
2021-01-29
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001352908
Hayden Michael R
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
2021-01-29
4
M
0
50000
5.44
A
50000
D
Common Shares
2021-01-29
4
M
0
30000
6.06
A
80000
D
Common Shares
2021-01-29
4
M
0
15000
6.42
A
95000
D
Stock Option (right to buy)
5.44
2021-01-29
4
M
0
50000
0
D
2028-02-22
Common Stock
50000.0
0
D
Stock Option (right to buy)
6.06
2021-01-29
4
M
0
30000
0
D
2029-01-29
Common Stock
30000.0
0
D
Stock Option (right to buy)
6.42
2021-01-29
4
M
0
15000
0
D
2029-07-03
Common Stock
15000.0
0
D
Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date.
/s/ Michael Hayden, Ph.D., M.D.
2021-02-01